In cervical squamous cell carcinoma (CSCC), upregulated FTO could promote β-catenin expression via demethylating its transcripts and further positively regulate the excision repair cross-complementation group 1 (ERCC1), contributing to the resistance to cisplatin and irradiation [132]. This evidence concerns the gene ERCC1 and skin squamous cell carcinoma.